What's new

Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 23, Status: Authorised

Feb 24, 2025 - 11:47
 0
Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 23, Status: Authorised
Read More

Tags:

Previous Article

Essential hotel tech for general managers

Next Article

Pre-authorisation guidance

Related Posts

Members of the Coordinating group of European network o...

Feb 10, 2025  0

Orphan designation: Adeno-associated virus serotype 5 vector encoding C1-esterase inhibitor Treatment of hereditary angioedema, 10/11/2022 Withdrawn

Orphan designation: Adeno-associated virus serotype 5 v...

Feb 20, 2025  0

Orphan designation: N-(4-(4-amino-5-(3-fluoro-4-((4-methylpyrimidin-2-yl)oxy)phenyl)-7-methyl-7H-pyrrolo[2,3-d] pyrimidin-6-yl)phenyl)methacrylamide hydrochloride Treatment of biliary tract cancer, 10/11/2022 Positive

Orphan designation: N-(4-(4-amino-5-(3-fluoro-4-((4-met...

Feb 24, 2025  0